Publications

Phage-encoded combinatorial chemical libraries based on bicyclic peptides Nature Chemical Biology vol. 5, pp 502–507, 2009

Bicyclic peptides with optimized ring size inhibit human plasma kallikrein and its orthologues while sparing paralogous proteases ChemMedChem vol. 7, pp 1173–1176, 2012

 

PRESENTATIONS AT PREVIOUS MEETINGS


March 2017

Cowen and Company 37th Annual Health Care Conference

 

November 2016
28th EORTC-NCI-AACR MOLECULAR TARGETS AND CANCER THERAPEUTICS SYMPOSIUM, Munich, Germany

-Development of BT1718, a Bicycle Drug Conjugate® (BDC) targeting MT1-MMP for treatment of solid tumours

-Design and characterization of a high affinity and selective bicyclic peptide binder to MT1-MMP for development of a treatment for solid tumours

 

July 2016
SMi’s 3rd annual Peptides event

-Development of cytotoxic bicyclic peptide drug conjugates and applications in molecular targeted cancer therapy

 

April 2016
3rd Annual Peptides Congress

-Development of Cytotoxic Bicyclic Peptide Drug Conjugates and Applications in Molecular Targeted Cancer Therapy

 

January 2016
Future of Healthcare Investor Forum

-Bicycle Therapeutics